Literature DB >> 9744317

Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.

B Al-Khafaji1, A E Noffsinger, M A Miller, G DeVoe, G N Stemmermann, C Fenoglio-Preiser.   

Abstract

Carcinoid tumors are potentially malignant neoplasms that arise in various body sites, including the lung and gastrointestinal tract. Those that appear cytologically atypical are more likely to behave aggressively than more typical carcinoid tumors. However, in the absence of cytological atypia or large tumor size, it is difficult to predict the biology of an individual tumor, because some lesions metastasize, whereas others do not. This study had four aims: (1) To study the expression pattern of p53, Ki-67, NCAM, and S-100 in carcinoid tumors and to relate these expression patterns to classical histopathologic features and to tumor location. (2) To identify nonhistological markers that might more accurately predict the early behavior of carcinoid tumors. (3) To determine whether sustentacular cells are present in carcinoid tumors arising in tissues derived from different embryological derivatives. (4) To determine the synaptophysin and chromogranin immunoreactivity in neuroendocrine tumors arising in various locations. The immunostaining reactions were quantitatively scored by three observers. Only 3 of the 39 tumors (all histologically atypical) were strongly positive for Ki-67; two of these were also strongly p53 immunoreactive. NCAM immunostaining differed according to the site of origin: 76.5% of foregut lesions, 58% of the midgut lesions, and 20% of hindgut lesions were positive. S-100 immunostaining ranged from 41% in foregut lesions to 50% in both the hindgut- and midgut-derived tumors. S-100-positive sustentacular cells were present in 20.5% of carcinoid tumors. All tumors stained with antibodies against synaptophysin. In contrast, 100% of midgut, 60% of hindgut, and 88% of foregut tumors were chromogranin positive. Carcinoid tumors tend to have low proliferative rates. p53 immunostaining tends to be strongly positive in tumors that are histologically atypical, but it is negative in typical carcinoid tumors arising in the gastrointestinal tract and lungs. Immunostaining reactions with antibodies to NCAM, S-100, and chromogranin differ depending on the site of origin. Synaptophysin stains 100% of carcinoid tumors regardless of their site of origin. In contrast, antibodies to chromogranin fail to stain 40% of hindgut tumors and 12% of foregut carcinoid tumors. S-100-positive sustentacular cells are present in foregut and midgut tumors but not in hindgut tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744317     DOI: 10.1016/s0046-8177(98)90206-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

Review 1.  Practical markers used in the diagnosis of neuroendocrine tumors.

Authors:  Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

2.  Uveal metastasis 43 years after resection of bronchogenic carcinoid.

Authors:  E D E Kaiser; R F See; A K Rechdouni; Y Usui; J I Lim; N A Rao
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

Review 3.  Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?

Authors:  Andrew M Bellizzi
Journal:  Hum Pathol       Date:  2019-12-17       Impact factor: 3.466

Review 4.  Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.

Authors:  Georgios Kyriakopoulos; Vasiliki Mavroeidi; Eleftherios Chatzellis; Gregory A Kaltsas; Krystallenia I Alexandraki
Journal:  Ann Transl Med       Date:  2018-06

5.  Malignant tumors of the small intestine: a histopathologic study of 41 cases among 1,312 consecutive specimens of small intestine.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

6.  Recurrence of primary hepatic carcinoid tumor in the remnant liver 13 yr after resection.

Authors:  Hiroyuki Nishimori; Kunihiko Tsuji; Noriyuki Miyamoto; Yasuo Sakurai; Shinya Mitsui; Jong-Hon Kang; Masafumi Yoshida; Masashi Nomura; Itokawa Fuminori; Hirotoshi Ishiwatari; Takahiro Matsunaga; Manabu Osanai; Akio Katanuma; Kuniyuki Takahashi; Yoshinori Anbo; Tomoshige Masuda; Nobuichi Kashimura; Toshiya Shinohara; Hiroyuki Maguchi
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 7.  Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Andrew M Bellizzi
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

8.  Immunohistochemical features of the gastrointestinal tract tumors.

Authors:  Hannah H Wong; Peiguo Chu
Journal:  J Gastrointest Oncol       Date:  2012-09

Review 9.  Overdiagnosis of a typical carcinoid tumor as an adenocarcinoma of the lung: a case report and review of the literature.

Authors:  Ilhan Demirci; Susanne Herold; Andreas Kopp; Michael Flaßhove; Bernd Klosterhalfen; Hermann Janßen
Journal:  World J Surg Oncol       Date:  2012-01-23       Impact factor: 2.754

10.  Histopathology of gastrointestinal neuroendocrine neoplasms.

Authors:  Kenichi Hirabayashi; Giuseppe Zamboni; Takayuki Nishi; Akira Tanaka; Hiroshi Kajiwara; Naoya Nakamura
Journal:  Front Oncol       Date:  2013-01-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.